Persistent graft-versus-host disease (GVHD) influences approximately one in 2 individuals that go through a stem cell transplant. Client advocacy teams are revealing us where treatment systems fail and what needs to transform. February 17 is GVHD Day. For the worldwide transplant neighborhood, it’s an important time to raise awareness concerning Graft-Versus-Host-Disease. For me, it’s […]
Source: Euractiv
